Sanofi Income from Continuous Operations 2012-2026 | SNY

Sanofi income from continuous operations for the twelve months ending March 31, 2026 was $5.686B, a 13.55% decline year-over-year.

  • Sanofi annual income from continuous operations for 2025 was $5.631B, a 6.31% decline from 2024.
  • Sanofi annual income from continuous operations for 2024 was $6.01B, a 2.15% increase from 2023.
  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.

Sanofi Income from Continuous Operations 2012-2026 | SNY

  • Sanofi annual income from continuous operations for 2025 was $5.631B, a 6.31% decline from 2024.
  • Sanofi annual income from continuous operations for 2024 was $6.01B, a 2.15% increase from 2023.
  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B